31 Mar 2022
Assets68.58
Total Income92.67
Profit After Tax3.13
NET Worth12.09
Reserves and Surplus11.69
Total Borrowing18.81
Open 19th Feb 2024 · Close 22nd Feb 2024 · Listing 27th Feb 2024
The shares listed at ₹110.00, a 39.24% move from the issue price. Zenith Drugs is a SME IPO with an issue size of ₹40.68 crore, proposed for listing on NSE SME. The offer opens on 19th Feb 2024 and closes on 22nd Feb 2024. The issue structure includes a fresh issue of ₹33.94 crore. The current listing schedule points to 27th Feb 2024.
| Investor | Lots | Shares | Amount |
|---|---|---|---|
| Minimum Bid | 1 | 1600 | ₹126,400 |
| Object | Amount |
|---|---|
| Purchase of Machinery & Equipments for Setting up New Unit | ₹10.61 Cr |
| Existing Manufacturing Block Upgradation | ₹2.11 Cr |
| Working Capital Requirements | ₹14.40 Cr |
| General Corporate Purposes | ₹8.84 Cr |
| Total | ₹35.96 Cr |
| KPI |
|---|
| ROE |
| ROCE |
| Debt / Equity |
| RoNW |
| PAT Margin |
| Price to Book Value |
| Expense | Amount |
|---|---|
| Payment to the Lead Manager | ₹1.30 Cr |
| Underwriting Fees | ₹1.03 Cr |
| Market Making Fees | ₹2.14 Cr |
| Fees payable to Registrar to Issue | ₹0.03 Cr |
| Fees to Legal Advisor | ₹0.02 Cr |
| Advertisement Expenses | ₹0.05 Cr |
| Fees payable to Regulators including Stock Exchange & Depositories | ₹0.08 Cr |
| Printing & Distribution Expenses | ₹0.01 Cr |
| Marketing & Selling Expenses | ₹0.03 Cr |
| Payment to Sponsor Bank | ₹0.02 Cr |
| Statutory & Other Reports | ₹0.02 Cr |